Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide.Aim of the study to assess the value of transforming beta binding protein-1 in plasma as a biomarker for early detection of hepatocellular carcinoma in chronic hepatitis C infection.Patients and methods: This cross-sectional prospective, case-control hospital based st...
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide.Aim of the study to assess the value of transforming beta binding protein-1 in plasma as a biomarker for early detection of hepatocellular carcinoma in chronic hepatitis C infection.Patients and methods: This cross-sectional prospective, case-control hospital based st...